Form D · Pharmaceuticals
Adtech Pharma, Inc.
Warwick, RI · CIK 0001892920
Offering snapshot reported Apr 12, 2022 · SEC filing
- Reported sold
- $1.11M Offering amount: $2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 31, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2022 | Initial | $1,105,000 | No comparison | 12 | SEC filing |
| Nov 9, 2021 | Initial | $1,877,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $111K
- Finders' fees
- $0
- Form D file number
- 021-441552
Total Offering Amount includes $400,000 which may be sold pursuant to an over-allotment option
Recipient also received $55,250 as a non-accountable expense allowance.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Spartan Capital Securities, LLC | 146251 |
Source: Form D, filed Apr 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lex Adjei | Director, Executive |
| Jodi Brichan | Director |
| Ping Chang | Director, Executive |
| Robert Kupper | Director, Executive |
| Iok Pang | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
755 Major Potter Road
Warwick, RI, 02818
Warwick, RI, 02818